Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Romualdo Vacchini
Safety, Effectiveness, and Impact on Quality of Life of Self-Administration With Plasma-Derived Nanofiltered C1 Inhibitor (Berinert®) in Patients With Hereditary Angioedema: The SABHA Study
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Related publications
Quality of Life Evaluation in Hereditary Angioedema Patients on Home Plasma Derived C1 Inhibitor Infusion
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor
Therapeutics and Clinical Risk Management
Pasteurized and Nanofiltered, Plasma-Derived C1 Esterase Inhibitor Concentrate for the Treatment of Hereditary Angioedema
Immunotherapy
Oncology
Allergy
Immunology
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
Biologics in Therapy
Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
New England Journal of Medicine
Medicine
Erratum To: Human Plasma-Derived, Nanofiltered C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting From C1-Inhibitor Deficiency
Biologics in Therapy
Determinants of Health Related Quality of Life (HRQoL) in Adult Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency (C1-Inh-Hae)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Treatment of Patients With Hereditary Angioedema With Normal C1 Inhibitor: Evaluation of 295 Patients
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?
Journal of Allergy and Clinical Immunology
Allergy
Immunology
